Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATIC | P31939 | 4/20 | 0.49 |
| ▸ | SHMT1 | P34896 | 3/20 | 0.49 |
| ▸ | SHMT2 | P34897 | 3/20 | 0.49 |
| ▸ | DHFR | P00374 | 5/20 | 0.48 |
| ▸ | GART | P22102 | 6/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | TYMS | P04818 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9047109 | 0.92 | CA2 (0.47) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL573199 | 0.86 | DHFR (0.52) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9045940 | 0.86 | ATIC (0.47) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9046201 | 0.83 | TAS1R3 (0.41) | ATICSHMT1SHMT2CA2CA1 | |
| SCHEMBL9043718 | 0.81 | ATIC (0.43) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9044214 | 0.80 | DHFR (0.46) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9049515 | 0.79 | CA2 (0.44) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9049344 | 0.79 | CA2 (0.43) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9046824 | 0.75 | ATIC (0.55) | ATICSHMT1SHMT2DHFRGART | |
| SCHEMBL9045484 | 0.74 | CYP4A11 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0432677-B1 | N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives | UNIV PRINCETON (US) | 1996-03-06 | — | — | EP | claimed |
| US-4996206-A | Antitumor agent | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1991-02-26 | — | — | US | claimed |
| JP-8003166-A | — | — | None | — | — | JP | disclosed |
| EP-0432677-B1 | N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives | UNIV PRINCETON (US) | 1996-03-06 | — | — | EP | disclosed |
| JP-H083166-A | N-(PYRROLO(2,3-D)PYRIMIDIN-3-YLACYL)GLUTAMIC ACID DERIVATIVE | UNIV PRINCETON | 1996-01-09 | — | — | JP | disclosed |
| US-5426187-A | Process for the preparation of 4-hydroxy-5-substituted ethynylpyrrolo [2,3-d]pyrimidine intermediates | ELI LILLY AND COMPANY (US) | 1995-06-20 | — | — | US | disclosed |
| US-5344932-A | N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives | TRUSTEES OF PRINCETON UNIVERSITY (US) | 1994-09-06 | — | — | US | disclosed |
| US-5248775-A | Pyrrolo(2,3-d)pyrimidines | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1993-09-28 | — | — | US | disclosed |
| EP-0432677-A1 | N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1991-06-19 | — | — | EP | disclosed |
| US-4996206-A | Antitumor agent | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1991-02-26 | — | — | US | disclosed |
| US-4996206-A | Antitumor agent | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1991-02-26 | — | — | US | disclosed |